Topic: Coronavirus

Latest content

Bypass covid-19 drug patents demand US state attorney generals

The pandemic has puts compulsory licensing firmly on the agenda in the country that is friendliest to life sciences IP owners

11 August 2020

How compulsory patent licensing could be used to combat covid-19 in the Americas

As the race to find coronavirus cures intensifies, we explore how legislation might be deployed in Brazil, Canada, Mexico and the US to ensure inventions are shared

05 August 2020

No evidence that patents are acting as a barrier to covid research, says Bristol Myers IP head

Pharma giant’s deputy general counsel Henry Hadad reflects on how work has changed during the pandemic and why more still needs to be done on 101 reform

04 August 2020

After PTAB upholds key patent, covid-19 vaccine fight heads to court

Moderna set to face infringement battle over its mRNA-1273, a hot prospect in the fight against coronavirus

04 August 2020

Ignore naysayers, the patent system is playing a vital role in the fight against covid-19

We have learned some important IP lessons in the months since the coronavirus pandemic surged across the world; one of which is just how crucial IP itself is to finding a way out of the crisis

01 August 2020

Indonesia makes compulsory licensing easier as high-tech waits on key patent reform

Country paves way for possible covid-19 vaccine order, but promised protections for technology firms are taking longer than anticipated

27 July 2020

After success of early stage covid-19 vaccine trial, Oxford University's coronavirus IP policy explained

With the promising news today that a coronavirus vaccine being developed by scientists at the university is safe and triggers an immune response, we revisit our exclusive April interview with the head of Oxford's tech transfer office in which he talks about its new, expedited, approach to granting covid-related licences

20 July 2020

How a platform technology patent list can expedite covid-19 vaccine research

More transparency around IP ownership in this vital area will help the development of treatments designed to tackle the coronavirus

07 July 2020

It’s a great time to be involved in IP finance

Why you should expect an increase in patent-focused financing deals involving biotech and other life sciences companies

13 June 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM

08 June 2020

Unlock unlimited access to all IAM content